StockNews.com assumed coverage on shares of Mannatech (NASDAQ:MTEX – Free Report) in a research report released on Wednesday morning. The brokerage issued a buy rating on the stock.
Mannatech Stock Performance
Shares of MTEX opened at $8.19 on Wednesday. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.07 and a quick ratio of 0.51. The stock has a 50-day moving average of $8.57 and a 200-day moving average of $8.76. The company has a market cap of $15.40 million, a PE ratio of -6.82 and a beta of 1.20. Mannatech has a one year low of $7.50 and a one year high of $15.10.
Mannatech (NASDAQ:MTEX – Get Free Report) last issued its earnings results on Thursday, March 28th. The company reported ($0.94) EPS for the quarter. The firm had revenue of $32.69 million during the quarter. Mannatech had a negative net margin of 1.70% and a negative return on equity of 19.19%.
Mannatech Company Profile
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
Further Reading
- Five stocks we like better than Mannatech
- What Does a Stock Split Mean?
- MarketBeat Week in Review – 4/22 – 4/26
- How to Use High Beta Stocks to Maximize Your Investing Profits
- 3 Stocks Leading the U.S. Agriculture Comeback
- What is the S&P 500 and How It is Distinct from Other Indexes
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
